Literature DB >> 24393754

The AWAKEN survey: knowledge of narcolepsy among physicians and the general population.

Russell Rosenberg1, Ann Y Kim.   

Abstract

Narcolepsy can be a debilitating sleep disorder resulting from the dysregulation of pathways that control the sleep and wake states of patients. Although overall knowledge of narcolepsy has increased, no previous studies characterize awareness and perceptions of this condition in the general population or among physicians. Our survey evaluated the understanding and perceptions of narcolepsy among individuals from the general population and from a sample of physicians, including sleep specialists. The Awareness and Knowledge of Narcolepsy (AWAKEN) survey included a sample of 1000 US adults, 300 primary care physicians (PCPs), and 100 sleep medicine specialists (36% board certified) and was conducted online by Harris Interactive in May 2012. Descriptive analysis was performed using 2-tailed t tests with a significance of P < 0.05. Although 70% of the general public respondents had heard of narcolepsy, it ranked lowest in awareness relative to other chronic diseases requiring long-term treatment. Overall, 62% of sleep specialists and 24% of PCPs considered themselves "very" or "extremely" knowledgeable about narcolepsy; however, only 42% and 9% of sleep specialists and PCPs, respectively, felt "very" or "extremely" comfortable diagnosing the disorder. Only 22% of sleep specialists and 7% of PCPs identified all 5 key narcolepsy symptoms; no participant in the general population could identify all 5 symptoms. Sixty-three percent of sleep specialists and 39% of PCPs recognized both of the most prominent narcolepsy symptoms, which are excessive daytime sleepiness and cataplexy. Substantial gaps exist in understanding narcolepsy and its symptoms, even among sleep medicine specialists. Our findings suggest a need for educational initiatives for physicians to improve recognition of narcolepsy symptoms.

Entities:  

Mesh:

Year:  2014        PMID: 24393754     DOI: 10.3810/pgm.2014.01.2727

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  12 in total

1.  The utility of a 5(th) nap in multiple sleep latency test.

Authors:  Rexford Muza; Dimosthenis Lykouras; Kate Rees
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

2.  The Treatment of Narcolepsy With Amphetamine-Based Stimulant Medications: A Call for Better Understanding.

Authors:  Moshe Turner
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

3.  Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.

Authors:  Richard K Bogan; Thomas Roth; Jonathan Schwartz; Maja Miloslavsky
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

4.  Medical specialty visits and diagnoses received by Saudi patients prior to a diagnosis of narcolepsy.

Authors:  Aljohara S Almeneessier; Sara Al-Jebrin; Reem Labani; Hussain Alkaff; Omar Al-Rahbeeni; Musab Alageel; Awad Olaish; Ahmed S BaHammam
Journal:  Sleep Breath       Date:  2019-02-28       Impact factor: 2.816

Review 5.  Patient-Reported Measures of Narcolepsy: The Need for Better Assessment.

Authors:  Ulf Kallweit; Markus Schmidt; Claudio L Bassetti
Journal:  J Clin Sleep Med       Date:  2017-05-15       Impact factor: 4.062

6.  Prevalence, incidence, and health care utilization of patients with narcolepsy: a population-representative study.

Authors:  Ulf Kallweit; Georg Nilius; Daniel Trümper; Tobias Vogelmann; Tino Schubert
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

7.  Development and Validation of the Pediatric Hypersomnolence Survey.

Authors:  Kiran Maski; Jennifer Worhach; Erin Steinhart; Madeline Boduch; Anne Marie Morse; Michael Strunc; Thomas Scammell; Judith Owens; Lindsay Jesteadt; Claire Crisp; David Williams; Georgios Sideridis
Journal:  Neurology       Date:  2022-03-21       Impact factor: 11.800

Review 8.  The Medical and Economic Burden of Narcolepsy: Implications for Managed Care.

Authors:  Michael J Thorpy; George Hiller
Journal:  Am Health Drug Benefits       Date:  2017-07

9.  Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States.

Authors:  Kathleen F Villa; Nancy L Reaven; Susan E Funk; Karen McGaughey; Jed Black
Journal:  Am Health Drug Benefits       Date:  2018-05

10.  Current and Future Treatment Options for Narcolepsy: A Review.

Authors:  Jackie Bhattarai; Scott Sumerall
Journal:  Sleep Sci       Date:  2017 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.